A study by Wu et al (2015) shows that ovarian cancer patients who did not respond to standard platinum-based chemotherapies express elevated levels of COL11A1 [65], where COL11A1 was one of the top overexpressed genes. This evidence concerns the gene COL11A1 and ovarian cancer.